Depletion of eIF2&#x00B7;GTP&#x00B7;Met-tRNAi translation initiation complex up-regulates BRCA1 expression  in vitro  and  in vivo

Bertal H. Aktas; Paula Bordelois; Selen Peker; Sophia Merajver; Jose A. Halperin

doi:10.18632/oncotarget.3125

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Depletion of eIF2·GTP·Met-tRNAi translation initiation complex up-regulates BRCA1 expression in vitro and in vivo

Bertal H. Aktas _, Paula Bordelois, Selen Peker, Sophia Merajver and Jose A. Halperin

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2015; 6:6902-6914. https://doi.org/10.18632/oncotarget.3125

Metrics: PDF 1581 views | HTML 2517 views | ?

Abstract

Bertal H. Aktas1,2,*, Paula Bordelois2,*, Selen Peker1,3, Sophia Merajver4, Jose A. Halperin1,2

1Division of Hematology, Brigham and Women's Hospital, Boston, MA, USA

2Harvard Medical School, Boston, MA, USA

3Ankara University Biotechnology Institute, Ankara, Turkey

4Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA

*These authors have contributed equally to this work

Correspondence to:

Jose A. Halperin, e-mail: [email protected]

Keywords: BRCA1, EPA, Fish Oil, eIF2·GTP·Met-tRNAi, uORF

Received: November 04, 2014 Accepted: January 09, 2015 Published: February 07, 2015

ABSTRACT

Most sporadic breast and ovarian cancers express low levels of the breast cancer susceptibility gene, BRCA1. The BRCA1 gene produces two transcripts, mRNAa and mRNAb. mRNAb, present in breast cancer but not in normal mammary epithelial cells, contains three upstream open reading frames (uORFs) in its 5’UTR and is translationally repressed. Comparable tandem uORFs are characteristically seen in mRNAs whose translational efficiency paradoxically increases when the overall translation rate is decreased due to phosphorylation of eukaryotic translation initiation factor 2 α (eIF2α). Here we show fish oil derived eicosopanthenoic acid (EPA) that induces eIF2α phosphorylation translationally up-regulates the expression of BRCA1 in human breast cancer cells. We demonstrate further that a diet rich in EPA strongly induces expression of BRCA1 in human breast cancer xenografts.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 3125

Publication Alerts

Research Papers:

Depletion of eIF2·GTP·Met-tRNAi translation initiation complex up-regulates BRCA1 expression in vitro and in vivo

Abstract